Two derivatives of a known GLUT5 inhibitor that prevent fructose transport in the micromolar to nanomolar range are identified using in-silico molecular docking and in vivo tumour xenograft experiments to determine the mechanism dictating essential fructose functions in cancer.
J. Groenendyk, K. Sahu, Lorne D. Tyrell et al.· Clinical Cancer Research· 0 citations
This review systematically summarizes the complex regulatory mechanisms of ITM2A in growth, development, and disease, with a particular focus on skeletal development and tumorigenesis, aiming to provide a theoretical basis for its potential use as a biomarker for development and disease diagnosis/treatment, as well as...
Xiaoling Deng, Yi-Fang Wang, Lan Yang et al.· iScience· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.